-
PLUROL OLEIQUE CC 497 [Co-surfactant] Polyglycerol oleate
Time of Update: 2021-07-29
Basic skin irritation and corrosiveness (pure substance): Not classified .
Eye irritation and reversibility (pure substance): unclassified .
Bacterial reverse mutation test (Ames test) (pure substance): Not classified .
-
TEFOSE 63 [emulsifier] polyethylene glycol-7-stearate
Time of Update: 2021-07-29
TEFOSE 63 [Emulsifier]Chemical name : Polyethylene glycol-7-stearateEnglish name : Pegoxol-7 StearateApplication : Non-ionic emulsifier . At 10-20% usage level, it is used to form a stable and bright
-
Discovery of brain repair may lead to new treatments for epilepsy
Time of Update: 2021-07-27
Using high-energy imaging technology, researchers have discovered for the first time that a type of immune cell called microglia not only removes damaged substances after an experimental seizure, but also seems to be repairing damaged neurons .
-
Zhenhe Technology releases an integrated IVD solution, deploying molecular diagnostic automation
Time of Update: 2021-07-27
At this conference, Zhenhe Technology released a new IVD overall solution for the first time, including the first domestic NGS companion diagnostic kit that focuses on colorectal cancer, the Genecast Genius G1 automatic sample processing system, and the Genecast INTEGRO V1.
-
New breakthroughs in the scientific community!
Time of Update: 2021-07-26
The results of this research form the basis of the Intestinal Phage Database (GPD), which will be a valuable resource for future research on bacteriophages and their role in regulating human health.
-
First acquaintance of a text: the ill-fated aristolochic acid!
Time of Update: 2021-07-26
In 2003, the "Longdan Xiegan Pill Incident" occurred; in the same year, the CFDA cancelled the medicinal standards for Guan Mutong; in the same year, many regions including Taiwan, China, had banned the use of the supplement; in the same year, the World Health Organization's International Cancer The research center lists aristolochic acid as a "category carcinogen" .
-
The State Food and Drug Administration discloses the latest developments in the development of new crown vaccines
Time of Update: 2021-07-26
At present, a total of 22 drugs have been urgently approved to carry out clinical trials for the treatment and prevention of new coronary pneumonia and its related indications; 2 drugs have been approved for listing with conditions; 54 new coronavirus detection reagents have been urgently approved, with a daily production capacity of 24.
-
Nature Sub-Journal: It was genes that decided to take a nap!
Time of Update: 2021-07-26
Through GWAS analysis of 13,304,133 high-quality estimated genetic variants of these participants, the researchers identified 123 regions in the human genome that are associated with daytime naps .
-
Zejing Pharmaceutical: Phase II clinical trial of Jacketinib Hydrochloride Tablets achieved successful results
Time of Update: 2021-07-26
Clinical trial status "Multi-center Phase II Clinical Trial on the Safety and Effectiveness of Jacketinib Hydrochloride Tablets in the Treatment of Middle- and High-risk Myelofibrosis Patients" (plan number: ZGJAK002) was carried out in more than 10 hospitals including the First Affiliated Hospital of Zhejiang University School of Medicine .
-
TJBio announces that TJ210/MOR210 has been approved by NMPA for Phase 1 clinical trials
Time of Update: 2021-07-26
The China Phase 1 clinical study of TJ210/MOR210 is an open-label, multi-dose, dose-climbing trial designed to evaluate its safety, tolerability and PK/PD in patients with relapsed or refractory advanced solid tumors .
-
Concord Kirin's first OX40-targeted monoclonal antibody KHK4083 Phase II clinical success
Time of Update: 2021-07-26
Kyowa Kirin recently announced that the Phase 2 study evaluating the antibody drug KHK4083 for the treatment of moderate to severe atopic dermatitis (AD) in adult patients has reached its primary endpoint .
-
Say no to obesity!
Time of Update: 2021-07-25
First, the research team established a mouse model of obesity-accelerated breast cancer, and experimentally confirmed that the tumors of obese mice were significantly larger than those of normal mice, and that the tumors of mice on a high-fat diet increased significantly .
-
Sinopharm China Biotech Wuhan Institute of New Crown Vaccine Releases Interim Analysis Data of Phase III Clinical Trial
Time of Update: 2021-07-25
According to statistical analysis, the results of the interim analysis of the phase III clinical trial showed that the safety of the new coronavirus inactivated vaccine from the Wuhan Institute of Biological Products of Sinopharm Group was good.
-
Global medicine news GSK/Sanofi new crown vaccine "2.0 version" enters Phase 2 clinical trial, AbbVie JAK inhibitor Phase 3 clinical success
Time of Update: 2021-07-25
On February 22, local time, Sanofi and GlaxoSmithKline (GSK) jointly announced that after adjustments, the new version of the adjuvant-based recombinant protein-based new coronary pneumonia (COVID-19) vaccine jointly developed by the two parties entered Phase 2 clinical trials.
-
France's new crown detection method produces results within 10 minutes, which can be used with smartphones
Time of Update: 2021-07-25
On February 25, recently, French scientists said that they are developing a new type of new coronavirus detection method Corial-1 .
When the swab sample is in contact with the electrode of the device, an electric current will be generated and an image will be formed on the mobile phone.
-
Don't be afraid of poor eyesight!
Time of Update: 2021-07-25
Recently, researchers from the University of Utah in " PNAS on" published an article entitled Retinal bioavailability and functional effects of a synthetic very-long-chain polyunsaturated fatty acid in mice research results, which for the first time developed a large number of synthetic VLC -PUFA method, it is clearly found that supplementing VLC-PUFA can increase the retinal lipid level of normal mice and ELOVL4 enzyme-deficient mice, and improve their visual function .
-
One thing drops one thing!
Time of Update: 2021-07-25
Mtp53 inhibits cell-autonomous and non-cell signaling by interfering with the function of the cytoplasmic DNA sensing mechanism cGAS-STING-TBK1-IRF3, thereby promoting cancer cell growth and evading immune surveillance.
. Restoring TBK1 signal can bypass mtp53, restore immune cell function, activate immune surveillance, and eradicate cancer cells .
-
Are you wearing long trousers today?
Time of Update: 2021-07-25
Initially, researchers found that as humans migrated from Africa to the colder climates of Central and Northern Europe, the α-actinin-3 mutant gene increased, and at the same time, people's cold tolerance also increased!
The measurement results showed that people lacking α-actinin-3 during acute cold stress Will protect the core body temperature .
-
Nature Sub-Journal: Scientists have developed a new type of bacterial therapy to improve the condition of 2/3 patients with eczema
Time of Update: 2021-07-22
Subsequently, the researchers evaluated the safety of ShA9 on the skin of participants with AD, and designed a randomized, double-blind phase 1 human clinical trial to better understand the mechanism of action and explore the effects of ShA9 on humans.
-
Under what circumstances will the iron in our body rise?
Time of Update: 2021-07-22
The researchers found that the dysregulation of macrophage-specific hepcidin is a key factor in the age-related iron overload of GOF PIEZO1 mice .
